Protagonist Therapeutics Inc
NASDAQ:PTGX

Watchlist Manager
Protagonist Therapeutics Inc Logo
Protagonist Therapeutics Inc
NASDAQ:PTGX
Watchlist
Price: 84.77 USD 0.19% Market Closed
Market Cap: 5.3B USD

P/E
Price to Earnings

115.3
Current
8.4
Median
24.3
Industry
Higher than median
Higher than industry value

The Price to Earnings (P/E) ratio shows how much investors are willing to pay for each dollar of a company’s earnings. It’s calculated by dividing the company’s market value by its net income.

P/E
115.3
=
Market Cap
5.3B USD
/
Net Income
45.9m USD
All Countries
Close

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
-42.1
2-Years Forward
P/E
-72
3-Years Forward
P/E
-76.5